Chen Yong-He, Lu Jun, Nie Run-Cong, Liu Dan, Liu Ai-Hong, Deng Zi-Jian, Chen Xi-Jie, Xiang Jun, Chen Ying-Bo, Huang Chang-Ming, Chen Shi, Peng Jun-Sheng
Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Surgery, Guangdong Institute of Gastroenterology, Guangzhou, China.
Front Oncol. 2021 Apr 30;11:593470. doi: 10.3389/fonc.2021.593470. eCollection 2021.
According to the 8th edition AJCC staging manual, a least of 16 lymph nodes retrieval (LNRs) is the minimal requirement for lymph nodes (LNs) dissection of gastric cancer surgery. Previous studies have shown that increasing the number of LNRs (≥30) prolongs survival for selected patients. However, the necessity of retrieving 30 or more LN for stage II gastric cancer patients is still under debate.
This study aims to explore the impact of retrieving 30 or more lymph nodes on the survival of stage II cancer patients.
A total of 1,177 patients diagnosed with stage II gastric cancer were enrolled in this study. The clinicopathological parameters and the impact of different LNRs (<30 or ≥30) and positive lymph node ratio (NR) on overall survival (OS) were retrospectively analyzed.
The mean number of LNRs was 34 ± 15. A total of 44% (518/1,177) of patients had an LNRs <30, while 56% (659/1,177) of patients had an LNRs ≥30. The 5-year survival rate was 81% for all patients, 76% for the LNRs <30 group, and 86% for LNRs ≥30 group, respectively (P = 0.003). The survival benefit of retrieving 30 lymph nodes was significant in certain subgroups: age >60 years/male/underwent total gastrectomy/stage IIB. For N+ patients, higher NR was significantly correlated with poor survival.
The survival benefit of retrieving 30 LNs varies in different subgroups. An LNRs of 30 is mandatory for selected stage II gastric cancer patients.
根据美国癌症联合委员会(AJCC)第8版分期手册,胃癌手术淋巴结清扫至少需要切除16枚淋巴结(LNR)。既往研究表明,增加LNR数量(≥30枚)可延长部分患者的生存期。然而,II期胃癌患者切除30枚或更多淋巴结的必要性仍存在争议。
本研究旨在探讨切除30枚或更多淋巴结对II期胃癌患者生存的影响。
本研究共纳入1177例诊断为II期胃癌的患者。回顾性分析临床病理参数以及不同LNR(<30或≥30)和阳性淋巴结比例(NR)对总生存期(OS)的影响。
LNR的平均数为34±15。共有44%(518/1177)的患者LNR<30,而56%(659/1177)的患者LNR≥30。所有患者的5年生存率为81%,LNR<30组为76%,LNR≥30组为86%(P=0.003)。在某些亚组中,切除30枚淋巴结的生存获益显著:年龄>60岁/男性/接受全胃切除术/IIB期。对于N+患者,较高的NR与较差的生存率显著相关。
切除30枚淋巴结的生存获益在不同亚组中有所不同。对于特定的II期胃癌患者,LNR为30是必要的。